The IL-1 receptor antagonist simultaneously inhibits SAA and stimulates fibrinogen synthesis and : A proposed mechanism of action: BUSM, Boston, MA 02118, Pfizer, Groton, CT 06340 and AFRRI, Bethesda, MD 20894
- 30 September 1991
- Vol. 3 (5) , 497
- https://doi.org/10.1016/1043-4666(91)90331-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: